drugset / Trial / NCT04225767

Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours

NCT04225767

NaSingle-groupOpen-labelTreatment

Summary

Phase II Investigation of Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours.

Timeline

Start
2020-02-18
Primary completion
2023-01-01
Completion
2023-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium carbonate Other / unclassified Other

Indications